Clinical Trial: Study of the Plasmodium Vivax Transmission-blocking Vaccine Pvs230D1-EPA/Matrix-M to Assess Safety, Immunogenicity, and Transmission-blocking Activity in Healthy Malaria-naive Adults
Study Status: Completed
Recruit Status: RECRUITING
Condition: Malaria
Study Type: INTERVENTIONAL
Official Title: Phase 1 Dose Escalation Study of The Plasmodium Vivax Transmission-Blocking Vaccine Pvs230D1-EPA/Matrix-M to Assess Safety, Immunogenicity, and Transmission-Blocking Activity in Healthy Malaria-N
Brief Summary:
Background:Malaria is a disease carried by mosquitoes in tropical countries around the world.It can cause symptoms like fever, body aches, and weakness.More than half a million people worldwide died of malaria in 2021, mostly children.Researchers want to find ways to prevent the spread of this disease.Objective:To test the effects of a new malaria vaccine.(Volunteers will not be exposed to malaria.)Eligibility:Healthy adults aged 18 to 50 years.Design:Volunteers will be screened.They will have a physical exam with…
Read more